RSV vaccine effectiveness across all ages
Introduction Respiratory syncytial virus (RSV) poses a significant threat, particularly to infants, young children, and older adults, causation acute respiratory infections. With over 30 million infants worldwide descending prey to RSV every year, it becomes material to find a vaccine that can battle this virus.Hospitalization is required for about 10% of the affected infants. Alarmingly, RSV infektions can be as severe as influenza … Read more